Agomelatine D6 is a deuterated form of the pharmaceutical compound agomelatine, where six hydrogen atoms are replaced with deuterium. It is used as a stable isotope-labeled compound in pharmaceutical research and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1079389-42-6
(+/-)-Ondansetron-d5 (methylimidazole-d5)
pharmaceutical raw material
Rifaximin-d6 (Major)
pharmaceutical raw material
Urapidil-d3 (methoxy-d3)
pharmaceutical raw material
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
pharmaceutical raw material
6-fluoro-3-hydroxypyrazine-2-carboxylic acid
pharmaceutical raw material
Dimepranol
pharmaceutical raw material
Tilmicosin
pharmaceutical raw material
Acetic acid--histidylseryl-alpha-aspartylglycylthreonylphenylalanylthreonylseryl-alpha-glutamylleucylserylarginylleucylarginyl-alpha-aspartylserylalanylarginylleucylglutaminylarginylleucylleucylglutaminylglycylleucylvalinamide (1/1)
pharmaceutical raw material
2,2,2-trideuterio-N-[2-[7-(trideuteriomethoxy)naphthalen-1-yl]ethyl]acetamide
YJYPHIXNFHFHND-WFGJKAKNSA-N
[2H]C([2H])([2H])C(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC([2H])([2H])[2H]